This paper is in the following e-collection/theme issue:

Tools, Programs and Algorithms (275) Clinical Information and Decision Making (1434) Decision Support for Health Professionals (1210) Innovations in Cancer Diagnostic and Decision Support (58) Lung Cancer (36)

Published on in Vol 9, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29017, first published .
An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review

Authors of this article:

Weilin Meng1 Author Orcid Image ;   Kelly M Mosesso2 Author Orcid Image ;   Kathleen A Lane2 Author Orcid Image ;   Anna R Roberts3 Author Orcid Image ;   Ashley Griffith3 Author Orcid Image ;   Wanmei Ou1 Author Orcid Image ;   Paul R Dexter3, 4, 5 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. O'Rourke J, Warnick J, Doole J, De Keyser L, Drebert Z, Wan O, Thompson C, London J, Fairchild K, Palchuk M. Exploring Breast Cancer Systemic Drug Therapy Patterns in Real-World Data. JCO Clinical Cancer Informatics 2023;(7) View
  2. Gendrin A, Souliotis L, Loudon-Griffiths J, Aggarwal R, Amoako D, Desouza G, Dimitrievska S, Metcalfe P, Louvet E, Sahni H. Identifying Patient Populations in Texts Describing Drug Approvals Through Deep Learning–Based Information Extraction: Development of a Natural Language Processing Algorithm. JMIR Formative Research 2023;7:e44876 View
  3. Ru B, Sillah A, Desai K, Chandwani S, Yao L, Kothari S. Real-World Data Quality Framework for Oncology Time to Treatment Discontinuation Use Case: Implementation and Evaluation Study. JMIR Medical Informatics 2024;12:e47744 View
  4. Liu S, Dasgupta A, Latremouille-Viau D, Rossi C, Rai P, Barlesi F, Leal T. Real-World Outcomes of First-Line Treatment With Anti–PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States. JCO Global Oncology 2024;(10) View
  5. Grady C, Hwang W, Reuss J, Iams W, Cass A, Liu G, Patel D, Liu S, Montenegro G, Patil T, Nieva J, Herrmann A, Marrone K, Lam V, Schwartzman W, Dowell J, Villaruz L, Miller K, Weiss J, Sun F, Velcheti V, Camidge D, Aggarwal C, Sun L, Marmarelis M. Determining Line of Therapy from Real‐World Data in Non‐Small Cell Lung Cancer. Pharmacoepidemiology and Drug Safety 2024;33(12) View